Case report: ZEB1 expression in three cases of hepatic carcinosarcoma.
Case report: ZEB1 expression in three cases of hepatic carcinosarcoma.
复制标题
DOI:
10.3389/fonc.2022.972650
复制
发表时间:
2022
影响因子:
4.7
通讯作者:
中科院分区:
文献类型:
--
作者:
Hepatic carcinosarcoma (HCS) is defined as a tumor that contains cancer from the epithelium and sarcoma from mesenchymal tissue. HCS has a low incidence rate and is composed of osteosarcoma, chondrosarcoma, or angiosarcoma. Though surgery is the main treatment for HCS, it has proven unsatisfactory, resulting in a very poor prognosis of HCS. Currently, the reports on HCS are mainly about the description of clinical pathological phenomena, imaging features, and mutation sites of related genes, the underlying molecular mechanism of HCS remains undefined. Through the dynamic process of epithelial-mesenchymal transition (EMT), cancer cells acquire a mesenchymal phenotype, simultaneously losing epithelial properties. Zinc finger E-box binding homeobox 1 (ZEB1) is an EMT-inducing transcription factor; its main regulatory target is E-cadherin in EMT process. Esophageal carcinosarcoma (ECS) is associated with EMT. The current study showed that EMT might promote the development of ECS and uterine carcinosarcoma (UCS), and ZEB1 was highly expressed in the sarcomatous components. In the current study, three cases were collected, and the clinicopathological features were compared with those of corresponding cases. The expression level, and subcellular localization of ZEB1 were detected using immunohistochemistry. The expression of the ZEB1 in the nucleus was found to be significantly higher in sarcomatous components than that in cancer components in all three cases, suggesting an association of HCS with EMT.
登录
查看更多内容
DOI:
10.1016/s1499-3872(11)60015-5
发表时间:
2011-02-01
影响因子:
3.3
作者:
Celikbilek, Mehmet;Deniz, Kemal;Ozbakir, Omer
通讯作者:
Ozbakir, Omer
影响因子:
2.9
作者:
Harada, Hiroki;Hosoda, Kei;Yamashita, Keishi
通讯作者:
Yamashita, Keishi
DOI:
10.1186/1756-9966-29-16
发表时间:
2010-02-24
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Liu Y;Ji R;Li J;Gu Q;Zhao X;Sun T;Wang J;Li J;Du Q;Sun B
通讯作者:
Sun B
影响因子:
37.3
作者:
Inoue H;Hashimura M;Akiya M;Chiba R;Saegusa M
通讯作者:
Saegusa M
DOI:
10.1016/j.bbrc.2018.08.098
发表时间:
2018-09-18
影响因子:
3.1
作者:
He, Chao;Wu, Tingting;Hao, Yongqiang
通讯作者:
Hao, Yongqiang